Filing Flows › Lemaitre Vascular (LMAT) › Q3 2026
Lemaitre Vascular (LMAT) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Lemaitre Vascular (LMAT) reported revenue of $68.0M for the third quarter 2026 (Q3 2026), +11% from a year earlier and -3% from the quarter before. Operating margin was 26.0%, net earnings $15.0M (22.1% of revenue).
Lemaitre Vascular, Q3 2026: revenue $68.0M (+11% year over year), operating margin 26.0%, net earnings $15.0M, operating cash flow $22.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $68.0M | -3% | +11% |
| Gross profit | $48.7M | -4% | +6% |
| Operating profit | $17.7M | -13% | -13% |
| Net earnings | $15.0M | -12% | -13% |
| Operating cash flow | $22.0M | +38% | -24% |
| Free cash flow | $19.7M | +44% | -26% |
What changed
Revenue was $68.0M in Q3 2026, up 11% year over year and down 3% from the previous quarter.
Gross margin was 71.7%, down 3.6 points from Q3 2025. Operating profit was $17.7M, a 26.0% margin (down 7.2 points year over year). Operating profit fell $2.6M even though revenue rose $6.9M versus Q3 2025, so costs grew faster than sales. Operating expenses grew 21% against revenue growth of 11%. The fastest-growing cost line was Research & development (+49%). Net earnings were $15.0M, down 13% year over year. The effective tax rate was 23.6%.
Operating cash flow was $22.0M (down 24% year over year), 146% of net earnings. Non-cash charges added back $2.9M of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items added $2.1M. Capital expenditures of $2.3M left free cash flow of $19.7M.
Questions
What was Lemaitre Vascular's revenue in the third quarter 2026?
Lemaitre Vascular (LMAT) reported revenue of $68.0M for the third quarter 2026 (Q3 2026), +11% from a year earlier and -3% from the quarter before.
Was Lemaitre Vascular profitable in the third quarter 2026?
Operating profit was $17.7M (26.0% of revenue) and net earnings $15.0M.
Source: Lemaitre Vascular 10-Q on SEC EDGAR.